Finasteride
Commons · Question 20625 · Tabled 17 Dec 2024 · Department of Health and Social Care · Official record
Answered 31 Dec 2024
Question
Asked by Kirsty Blackman
To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential impact of the sales Finasteride medications through telehealth companies on an increase in the level of cases of Post-Finasteride Syndrome in the
Answer
Answered by Karin Smyth, 31 Dec 2024
The Medicines and Healthcare products Regulatory Agency’s (MHRA) role is to continually monitor the safety of medicines during their use. We have robust, safety monitoring and surveillance systems in place for all healthcare products, including finasterid...